These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 17311509

  • 1. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome.
    Hahn S, Kuehnel W, Tan S, Kramer K, Schmidt M, Roesler S, Kimmig R, Mann K, Janssen OE.
    Clin Chem Lab Med; 2007; 45(2):202-7. PubMed ID: 17311509
    [Abstract] [Full Text] [Related]

  • 2. Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.
    Nadaraja RND, Sthaneshwar P, Razali N.
    Malays J Pathol; 2018 Apr; 40(1):33-39. PubMed ID: 29704382
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of different diagnostic methods for assessment of hyperandrogenism in young women with hirsutism.
    Chanukvadze D, Kristesashvili J.
    Georgian Med News; 2011 Nov; 11(200):25-9. PubMed ID: 22201076
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
    Chen F, Chen M, Zhang W, Yin H, Chen G, Huang Q, Yang X, Chen L, Lin C, Yin G.
    J Ovarian Res; 2021 Feb 14; 14(1):32. PubMed ID: 33583431
    [Abstract] [Full Text] [Related]

  • 5. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots.
    Barth JH, Field HP, Yasmin E, Balen AH.
    Eur J Endocrinol; 2010 Mar 14; 162(3):611-5. PubMed ID: 20008514
    [Abstract] [Full Text] [Related]

  • 6. Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies.
    Escobar-Morreale HF, Asunción M, Calvo RM, Sancho J, San Millán JL.
    Eur J Endocrinol; 2001 Nov 14; 145(5):619-24. PubMed ID: 11720881
    [Abstract] [Full Text] [Related]

  • 7. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF, Li X, Zhu MW.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct 14; 41(10):684-8. PubMed ID: 17199924
    [Abstract] [Full Text] [Related]

  • 8. The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents.
    Khashchenko E, Uvarova E, Vysokikh M, Ivanets T, Krechetova L, Tarasova N, Sukhanova I, Mamedova F, Borovikov P, Balashov I, Sukhikh G.
    J Clin Med; 2020 Jun 11; 9(6):. PubMed ID: 32545404
    [Abstract] [Full Text] [Related]

  • 9. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S, Dittrich R, Binder H, Kajaia N, Hoffmann I, Maltaris T, Beckmann MW, Mueller A.
    Exp Clin Endocrinol Diabetes; 2007 Jun 11; 115(6):380-6. PubMed ID: 17701884
    [Abstract] [Full Text] [Related]

  • 10. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul 11; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 11. Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia.
    Cho LW, Kilpatrick ES, Jayagopal V, Diver MJ, Atkin SL.
    Clin Endocrinol (Oxf); 2008 Mar 11; 68(3):390-4. PubMed ID: 17888022
    [Abstract] [Full Text] [Related]

  • 12. Testosterone and bioavailable testosterone help to distinguish between mild Cushing's syndrome and polycystic ovarian syndrome.
    Pall ME, Lao MC, Patel SS, Lee ML, Ghods DE, Chandler DW, Friedman TC.
    Horm Metab Res; 2008 Nov 11; 40(11):813-8. PubMed ID: 18819057
    [Abstract] [Full Text] [Related]

  • 13. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.
    Yetim A, Yetim Ç, Baş F, Erol OB, Çığ G, Uçar A, Darendeliler F.
    J Clin Res Pediatr Endocrinol; 2016 Sep 01; 8(3):288-97. PubMed ID: 27125339
    [Abstract] [Full Text] [Related]

  • 14. Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria.
    Mueller A, Dittrich R, Binder H, Hoffmann I, Beckmann MW, Cupisti S.
    Eur J Med Res; 2006 Dec 14; 11(12):540-4. PubMed ID: 17182367
    [Abstract] [Full Text] [Related]

  • 15. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), Androgen Excess and PCOS Society (AES).
    Endocr Pract; 2015 Nov 14; 21(11):1291-300. PubMed ID: 26509855
    [Abstract] [Full Text] [Related]

  • 16. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S, Atakul N, Aydogan B, Aydin Y, Imamoglu M, Seyisoglu H.
    Acta Obstet Gynecol Scand; 2013 Dec 14; 92(12):1369-74. PubMed ID: 23980726
    [Abstract] [Full Text] [Related]

  • 17. Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.
    Köninger A, Koch L, Edimiris P, Enekwe A, Nagarajah J, Kasimir-Bauer S, Kimmig R, Strowitzki T, Schmidt B.
    Arch Gynecol Obstet; 2014 Nov 14; 290(5):1023-30. PubMed ID: 24961320
    [Abstract] [Full Text] [Related]

  • 18. A prospective study of anti-mullerian hormone and other ovarian and adrenal hormones in adult female acne.
    Bansal P, Sardana K, Arora P, Khurana A, Garga UC, Sharma L.
    Dermatol Ther; 2020 Nov 14; 33(6):e13974. PubMed ID: 33185003
    [Abstract] [Full Text] [Related]

  • 19. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos GP, Creatsas G, Mastorakos G.
    J Clin Endocrinol Metab; 2011 Mar 14; 96(3):623-31. PubMed ID: 21177795
    [Abstract] [Full Text] [Related]

  • 20. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.
    Yue CY, Lu LK, Li M, Zhang QL, Ying CM.
    PLoS One; 2018 Mar 14; 13(8):e0203129. PubMed ID: 30153296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.